“…Generally, previous studies have reported that those with ARFID present for treatment at a younger age than those with AN (Bryson, Scipioni, Essayli, Mahoney, & Ornstein, ; Cooney et al, ; Fisher et al, ; Forman et al, ; Nakai, Nin, Noma, Teramukai, & Wonderlich, ; Nicely et al, ; Norris et al, ; Ornstein, Nicely, Lane‐Loney, Masciulli, & Hollenbeak, ) and, in outpatient settings, have a longer duration of illness than patients with AN (Fisher et al, ; Forman et al, ). A recent latent class analysis of children between the ages of 5 and 13 presenting to pediatric clinics or general psychological clinics reported that restrictive eating could be separated into two distinct classes: (1) a class similar to AN characterized by body dissatisfaction, fear of gaining weight, and over exercising; and (2) a class similar to ARFID characterized by somatic concerns and low levels of weight and shape concerns (Pinhas et al, ). Consistent across three samples from English‐speaking countries (United Kingdom, Australia, and Canada), the class similar to ARFID was younger with elevated levels of anxiety and, though not statistically significant, a longer duration of illness (Pinhas et al, ).…”